comparemela.com

Latest Breaking News On - Director emer cooke - Page 6 : comparemela.com

EMA Finds Possible Link Between J&J Vaccine, Blood Clot Events With Low Platelets

EMA Finds Possible Link Between J&J Vaccine, Blood Clot Events With Low Platelets
sputniknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sputniknews.com Daily Mail and Mail on Sunday newspapers.

J&J to Resume EU Vaccine Deliveries After Review of Clot Risk

J&J to Resume EU Vaccine Shipments After Review of Clot Risk Bloomberg 5 hrs ago Naomi Kresge © Bloomberg A shipment of the Johnson & Johnson Janssen Covid-19 vaccine arrives at Northwell Health South Shore University Hospital in Bay Shore, New York, U.S., on Wednesday, March 3, 2021. President Biden said that Merck & Co. will help make Johnson & Johnson s single-shot coronavirus vaccine, a collaboration between rivals aimed at ramping up the pace of inoculations that will help provide enough supply for every adult in the U.S. by the end of May. (Bloomberg) Johnson & Johnson will restart deliveries of its Covid-19 vaccine to the European Union after the bloc’s drug regulator said the benefits of the shot outweigh the risks of a possible link with cases of rare blood clots.

EU Regulator: Possible Link Between Johnson & Johnson Vaccine And Rare Blood Clots

Boxes containing the Janssen Johnson & Johnson COVID-19 vaccine, shown at a vaccination center in Los Angeles last week. The European Union s drug regulator said Tuesday it had concluded there is a possible link between the Johnson & Johnson COVID-19 vaccine and several cases in the U.S. of a rare type of blood clot, but emphasized that the shot s benefits in preventing COVID-19 outweigh the risks of side effects. The assessment by the European Medicines Agency, or EMA, comes a week after the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration announced a pause in the distribution of the Johnson & Johnson vaccine, developed by the company s Janssen Pharmaceuticals unit, after reporting six cases of cerebral venous sinus thrombosis a rare type of blood clot seen in combination with low levels of blood platelets.

EU regulator backs J&J shot, finds possible link to clots

EU regulator backs J&J shot, finds possible link to clots By Pushkala Aripaka, Anthony Deutsch and John Miller Reuters (Reuters) -Europe s drug regulator has found a possible link between Johnson & Johnson s COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. The European Medicines Agency (EMA) said on Tuesday its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine s labels, just as it has also required of rival vaccine maker AstraZeneca. The review of the cases prompted a pause in the rollout of the vaccine in Europe and the United States last week, the latest blow to efforts to tackle the pandemic, which has killed more than 3.1 million and infected 142.1 million worldwide.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.